Announced Wed, 22 Jul · 15:48 IST
AstraZeneca India informs shareholders on TDS rules for FY26 final dividend
Compliance View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹8014.00
prior close
₹7970.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.0-0.1—-0.0+1.2————————
Up moveDown movePending
AI summary
AstraZeneca Pharma India informed shareholders about TDS on the proposed final dividend of Rs. 36 per share for FY 2025-26. AGM on August 10, 2026, record date July 31, 2026. Resident shareholders face 10 percent TDS with valid PAN, 20 percent otherwise. Non resident shareholders face 20 percent or lower DTAA rate. Required documents must be submitted by July 31, 2026 at 5 PM IST.
Likely market impact
Shareholders must submit tax documents by July 31, 2026 to avoid higher TDS deduction on the Rs. 36 per share dividend. Payout plan is unchanged.